Pune, India

Swapnil Panditrao Sonawane


 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Pune, IN (2010 - 2014)
  • Maharashtra, IN (2016)

Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Swapnil Panditrao Sonawane

Introduction

Swapnil Panditrao Sonawane is an accomplished inventor based in Pune, India, with a strong focus on pharmaceutical innovations. With a total of four patents to his name, he has made significant contributions to the field of drug synthesis, particularly in the area of new pharmaceutical compounds.

Latest Patents

His latest patents include a groundbreaking work on the synthesis of Raltegravir. This invention details a novel synthetic route for preparing Raltegravir and its pharmaceutically acceptable salts, beginning from 2-amino-2-methylpropanenitrile and oxadiazole carbonyl chloride. The process leads to the formation of a pyrimidinone intermediate of formula (V), showcasing an innovative approach in pharmaceutical chemistry.

Career Highlights

Throughout his career, Swapnil has worked with reputable companies such as Emcure Pharmaceuticals Limited and Lupin, Inc. These experiences have enriched his expertise in pharmaceutical development and production, allowing him to make influential strides in his field.

Collaborations

His collaborative efforts have included working alongside notable colleagues like Mukund Keshav Gurjar and Samit Satish Mehta. These partnerships have played a vital role in fostering creative and effective solutions in drug synthesis and innovation.

Conclusion

Swapnil Panditrao Sonawane stands out as a key figure in pharmaceutical innovation, with his patents reflecting a commitment to advancing drug synthesis. His contributions are valuable not only to his companies but also to the broader field of pharmaceuticals, paving the way for future developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…